Hyderabad-based Natco Pharma has approached the Delhi High Court with a petition seeking revocation of a patent held by Novo ...

The Medical Counselling Committee (MCC) of the Directorate General of Health Services (DGHS) has informed all State ...

USA: A randomized clinical trial published in JAMA Internal Medicine suggests that a collaborative care model adapted for low ...

PHARMEXCIL engaged senior Commerce and Pharma Ministry officials to align policy, boost MSME participation, and sustain India ...

Mandi: Authorities at Shri Lal Bahadur Shastri Medical College, Nerchowk, took disciplinary action against three MBBS ...

These products are among the largest oncology biologics expected to lose exclusivity over the next five years.

Thiruvananthapuram: The State Consumer Disputes Redressal Commission, Kerala recently exonerated a Kasargode-based hospital ...

For millions suffering from chronic inflammatory diseases like inflammatory bowel disease (IBD), managing flare-ups often ...

Nimbus will ⁠use its ⁠AI to help identify drug candidates, while Lilly will contribute its metabolic-disease expertise to ...

CEO Doustdar is trying to restore investor confidence by sharpening Novo's focus, after a tough year in which the company ...

Cipla had earlier received final USFDA approval in May 2024 to market its generic Lanreotide injection in multiple strengths.

Bhopal: The Directorate of Medical Education (DME Madhya Pradesh), has officially announced the postponement of the State Mop ...